Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b

C.H. Polman, L. Kappos, M.S. Freedman, G. Edan, H.P. Hartung, D. H. Miller, X. Montalban, F. Barkhof, K. Selmaj, B.M.J. Uitdehaag, S. Dahms, L. Bauer, C. Pohl, R. Sandbrink

Research output: Contribution to journalArticleAcademicpeer-review

67 Citations (Scopus)
Original languageEnglish
Pages (from-to)480-487
JournalJournal of neurology
Issue number4
Publication statusPublished - 2008

Cite this